An endotoxin result measures or limits bacterial endotoxin in the tested sample. It answers a different question from peptide identity, chromatographic purity, measured content or a microbial screen. On a COA, read the assay, result, unit, reporting limit and sample basis together. “Pass” without those details is a conclusion with too little context.
This guide is for research-use-only materials and laboratory-document evaluation. It provides no dosing or medical advice. Find the complete report in the COA library and inspect its verification evidence with the COA checker.
What endotoxin testing is looking for
Endotoxins are associated with Gram-negative bacteria. A bacterial endotoxin assay is not a count of living organisms and is not a comprehensive screen for every pyrogen. The FDA's technical guide to bacterial endotoxins and pyrogens explains this distinction. It is why a peptide purity result or a negative microbial result cannot substitute for a named endotoxin assay.
For documentary review, keep the target explicit. “Endotoxin tested” is a meaningful scope when the certificate records that test. “Contamination free” is much broader and cannot be reconstructed from a single result. An assay that reports below its detection threshold still has a threshold.
What LAL means on the method line
LAL stands for Limulus amebocyte lysate. Traditional LAL methods use a biological reagent that reacts in the presence of endotoxin. Results can be based on gel formation, a change in turbidity or a chromogenic signal. USP chapter 85, Bacterial Endotoxins Test, is the key compendial reference to recognize on a report.
A method label helps explain the kind of output available. A limit test can support a threshold conclusion, while a quantitative assay can provide a numerical result over its validated range. Do not turn a pass/fail endpoint into a precise concentration that the laboratory never reported. Retain the original inequality when the printed finding is “less than” a stated value.
Some laboratories use recombinant reagents rather than traditional lysate. The FDA's March 2026 guidance, Edition 2, discusses alternative bacterial endotoxin methods and appropriate validation. The method should be identified accurately on the certificate. Calling every endotoxin assay “LAL” can hide a real difference in the reagent and procedure used.
Read the unit before comparing two certificates
An endotoxin unit, or EU, expresses assay activity against a reference. The denominator changes the meaning of the result:
| Reported unit | What the number refers to | What must be clear |
|---|---|---|
| EU/mL | Activity per volume of the tested solution | Solution basis and any reported dilution correction |
| EU/mg | Activity relative to a mass basis | Which material mass the laboratory used |
| EU per vial | Activity assigned to the submitted vial | Whole-vial calculation and sample preparation basis |
These labels should survive any summary or spreadsheet entry. A lower-looking number is not automatically the lower endotoxin finding when the units differ. A result for a diluted laboratory solution also needs the issuer's stated calculation basis before it can be compared with a result normalized to original material.
For illustration, a hypothetical result below 0.05 EU/mL remains “below 0.05 EU/mL.” Rewriting it as zero discards the reporting limit. Rewriting it as below 0.05 EU per vial changes the denominator. Neither is a faithful transcription. Ask the issuing laboratory to explain an unclear basis rather than inventing a conversion from storefront information.
A valid result also needs a suitable sample method
The sample matrix can affect an endotoxin assay's response. Inhibition can reduce a signal, while enhancement can increase it. This is a method-suitability question, not something a reader can resolve by looking at the vial or choosing the most favorable result.
A positive product control adds a known endotoxin challenge to the sample preparation and checks recovery. A negative control helps assess contamination introduced by the analytical process. Charles River's endotoxin validation FAQ explains how product controls and dilution relate to assay validity. When the certificate omits these details, request the laboratory's supporting method documentation if the research decision depends on them.
The distinction between “not detected” and “test invalid” is especially important. A laboratory may need to address interference before reporting an interpretable result. A blank cell, an unreadable image or an incomplete assay does not supply a negative finding. Keep those states separate when comparing reports.
Acceptance criteria belong to a defined context
An acceptance criterion is the threshold against which the issuer assessed the result. It should be printed or traceable to the specified method and application. A certificate saying “pass” tells you the laboratory applied a criterion; it does not identify that criterion unless the report supplies it.
FDA guidance for regulated products addresses sampling, product characteristics and validated procedures. The current endotoxin guidance is useful for understanding those quality principles. This article does not convert regulated-product limits into personal-use thresholds for research peptides.
For a research documentation review, the actionable questions are narrower: what limit was used, on what sample basis, by which method, and was the result valid? Record the answers beside the accession and lot so a later reviewer can reproduce the comparison.
What PeptidePrices verified in eight vendor archives
These are September 25, 2026 snapshot counts from retained public evidence. Panel counts describe named results in public records, including historical certificates. They are not promises about every current item a vendor sells.
| Vendor | Issuer verification scope | Documented endotoxin coverage |
|---|---|---|
| Puratek Peptides | 42 of 42 reports matched | 41 of 42 reports |
| ZC Labs | 69 of 70 certificates matched | All 24 ILS reports in the archive |
| Rebirth Labs | All 119 public reports matched | 74 public records have extractable endotoxin panels |
| Modern Research Peptides | 124 downloadable reports verified; one unavailable historical record | 82 of the 124 downloaded reports |
| Glacier Aminos | 245 issuer matches plus 25 documentary-only public records | 253 of 270 public records have extractable endotoxin coverage |
| Refined BioLabs | All 25 public records issuer verified | 25 of 25 records |
| Validated Peptides | All 17 public reports issuer matched | 12 of 17 records |
| IDUN Peptides | All 48 public records issuer verified | 26 of 48 records |
Glacier's column includes documentary-only evidence, so its 253 panel records must not be called 253 issuer-verified endotoxin reports. The table deliberately separates the two counts. Puratek's reviewed reports span February 1 through August 24, 2026; ZC's span June 9 through September 23. Dates and denominators keep these examples specific.
The Modern Research Peptides archive also shows how a limit result can be preserved. Its retained GHK-Cu report, search code MRP2607300953, records two passing endotoxin replicates with assay sensitivity at or below 0.05 EU/mL. That wording belongs with the issuer's original result. It should not be shortened to “zero endotoxin,” and the laboratory's preparation basis remains relevant to any further interpretation.
Which laboratories document these panels?
In the merged public-library snapshot, 541 of 607 Kovera records and 425 of 698 ILS records have extractable endotoxin fields. Freedom contributes 637 such records among 2,120 public certificate records. These are lower-bound extraction counts across mixed historical and current evidence, not estimates of each laboratory's total production or testing competence.
Read the Kovera Labs, ILS Laboratories and Freedom Diagnostics profiles when checking issuer context. ILS's methods page specifically describes kinetic chromogenic LAL. A laboratory's service menu is useful context, but the selected report still needs its own method and result.
Match the panel to the exact research material
Open the certificate attached to the specific BPC-157, GLP-2T or GLP-3R listing under review. Compare vendor, compound, strength and unit, then read the lot and sample description. A historical endotoxin panel can remain valuable archive evidence without establishing the state of a newer batch.
Verify the report number and access code with the issuer, then compare the client and results. Keep a confirmed report separate from an unavailable portal, a no-match or a field conflict. PeptidePrices' numbers refer to these documentary checks; the series did not collect or retest physical samples.
For the rest of the report, read the core three-panel test, sterility and microbial testing, and heavy-metal testing. The complete COA guide connects the panels and gives the audit's counting method. Keep the endotoxin result as its own line of evidence, with its method, limit and units intact.